Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW

Takhzyro(lanadelumab)Lanadelumab Injection 达泽优(拉纳芦人单抗)

This product is suitable for preventing the occurrence of hereditary angioedema (HAE) in patients aged 12 years and above.

Share: